Butler J, Abildstrm SZ, Borlaug BA, Davies MJ, Kitzman DW, Petrie MC, Shah SJ, Verma S, Abhayaratna WP, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Nez J, Perna E, Schou M, Senni M, van der Meer P, von Lewinski D, Wolf D, Altschul RL, Rasmussen S, Kosiborod MN
It should contain detailed information including the patients diagnosis, the proposed treatment or service, the duration of the treatment, the providers information, why this treatment is medically necessary over other potential treatments, and how the treatment is expected to improve the patients condition
The Association has strict policies to prevent these relationships from influencing the science content
VEGF/Angiogenesis Pathway: BPC-157 stimulates VEGFR2, Akt-eNOS axis activation, and sustained NO synthesis, promoting new blood vessel formation
While this sounds encouraging, we must recognize this was not a controlled trial there was no placebo group, and the patients (and doctors) knew they were receiving the peptide